Clinical trials
Sarcopenia trials in Spain with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 6 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 9 |
| 2023 | 5 |
| 2024 | 10 |
| 2025 | 7 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Unknown status | 11 |
| Not yet recruiting | 10 |
| Recruiting | 8 |
| Active, not recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maimónides Biomedical Research Institute of Córdoba | 4 |
| University Rovira i Virgili | 4 |
| University of Salamanca | 4 |
| Cardenal Herrera University | 3 |
| Universidad de Granada | 3 |
| Universitat Internacional de Catalunya | 3 |
| Consorci Sanitari del Maresme | 2 |
| Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2 |
| Hospital Clinic of Barcelona | 2 |
| Hospital Universitari de Bellvitge | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcopenia | 65 |
| Frailty | 21 |
| Heart Failure | 4 |
| Malnutrition | 4 |
| Obesity | 4 |
| Renal Insufficiency, Chronic | 4 |
| Cognitive Dysfunction | 3 |
| Neoplasms | 3 |
| Cardiovascular Diseases | 2 |
| Coronary Artery Disease | 2 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.